These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11534982)

  • 21. Membrane-initiated signaling of estrogen in the brain.
    Rønnekleiv OK; Malyala A; Kelly MJ
    Semin Reprod Med; 2007 May; 25(3):165-77. PubMed ID: 17447206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia.
    Mhyre AJ; Dorsa DM
    Neuroscience; 2006; 138(3):851-8. PubMed ID: 16343790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of dopaminergic neurons in the mammalian brain.
    Prakash N; Wurst W
    Cell Mol Life Sci; 2006 Jan; 63(2):187-206. PubMed ID: 16389456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midbrain dopamine neuron differentiation: factors and fates.
    Abeliovich A; Hammond R
    Dev Biol; 2007 Apr; 304(2):447-54. PubMed ID: 17331494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo.
    Prakash N; Brodski C; Naserke T; Puelles E; Gogoi R; Hall A; Panhuysen M; Echevarria D; Sussel L; Weisenhorn DM; Martinez S; Arenas E; Simeone A; Wurst W
    Development; 2006 Jan; 133(1):89-98. PubMed ID: 16339193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of membrane and nuclear estrogen receptor signaling.
    Zhang D; Trudeau VL
    Comp Biochem Physiol A Mol Integr Physiol; 2006 Jul; 144(3):306-15. PubMed ID: 16516516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of estrogen signaling in male bone].
    Tsukui T; Imazawa Y; Inoue S
    Clin Calcium; 2006 Mar; 16(3):462-8. PubMed ID: 16508129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Midbrain dopaminergic neurons: control of their cell fate by the engrailed transcription factors.
    Simon HH; Thuret S; Alberi L
    Cell Tissue Res; 2004 Oct; 318(1):53-61. PubMed ID: 15340832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action.
    Koohi MK; Ivell R; Walther N
    J Neuroendocrinol; 2005 Apr; 17(4):197-207. PubMed ID: 15842231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling aversive events in the midbrain: worse than expected.
    Quirk GJ; Sotres-Bayon F
    Neuron; 2009 Mar; 61(5):655-6. PubMed ID: 19285461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nongenomic actions of estrogens: exciting opportunities for pharmacology.
    Wehling M; Schultz A; Lösel R
    Maturitas; 2006 Jul; 54(4):321-6. PubMed ID: 16730139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic and non-genomic effects of estrogens on endothelial cells.
    Simoncini T; Mannella P; Fornari L; Caruso A; Varone G; Genazzani AR
    Steroids; 2004 Aug; 69(8-9):537-42. PubMed ID: 15288766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen signaling: a subtle balance between ER alpha and ER beta.
    Matthews J; Gustafsson JA
    Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.
    Dluzen D; Horstink M
    Endocrine; 2003 Jun; 21(1):67-75. PubMed ID: 12777705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and the developing mammalian brain.
    Beyer C
    Anat Embryol (Berl); 1999 May; 199(5):379-90. PubMed ID: 10221449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging of brain: role of estrogen.
    Thakur MK; Sharma PK
    Neurochem Res; 2006 Nov; 31(11):1389-98. PubMed ID: 17061165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane receptors for oestrogen in the brain.
    Beyer C; Pawlak J; Karolczak M
    J Neurochem; 2003 Nov; 87(3):545-50. PubMed ID: 14535938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.